2-Oxo-2-phenylethyl ((benzyloxy)carbonyl)-L-alaninate, 98%, 1g

4-(2-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine hydrochloride, 95.0%, 1g

(3S)-3-Methylpiperidin-3-ol hydrochloride, 98%, 25g

3-(5-azetidin-3-yl-1,2,4-oxadiazol-3-yl)pyridine dihydrochloride, 95.0%, 250mg

2,4-DICHLORO-8-METHYLQUINOLINE, 95.0%, 250mg

4-Boc-7-Hydroxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 1g

2-Amino-3-(3-bromophenyl)propanoic acid, 95.0%, 500g

SULFAQUINOXALINE SODIUM, 95%, 1g

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate, 95.0%, 10g

5-dimethylamino-naphthalene-1-sulfonylchl, min. 98%, pa, 1 g, glass packaging

1-(1,1-Difluoroethyl)-3,5-difluorobenzene, 5g

1-((2-(Diethylamino)ethyl)amino)-4-(hydroxymethyl)-9H-thioxanthen-9-one, 95.0%, 50mg

(5-ethoxy-1H-benzimidazol-2-yl)methanol, 95.0%, 250mg